Table of Contents

September 01, 1995; Volume 62, Issue 5
  • Medical Grand Rounds

  • Internal Medicine Board Review

      • A 47-year-old woman with a swollen leg

        David L. Longworth, MD, James K. Stoller, MD, Rochelle Rosian, MD and Brian F. Mandell, MD, PhD
        • Cleveland Clinic Journal of Medicine September 1995, 62 (5) 281-284;
        • A self-test featuring a challenging clinical presentation.

  • Clinical Reviews

      • Coronary heart disease in African Americans: primary and secondary prevention

        Luther T. Clark, MD and Obinnaya Emerole, MD
        • Cleveland Clinic Journal of Medicine September 1995, 62 (5) 285-292;
        • How physicians can help improve the cardiovascular health of their black patients, who have a high level of CHD risk factors.

      • Asthma: current controversies and emerging therapies

        Mani S. Kavuru, MD, Lily Pien, MD, Dianne Litwin, MD, Serpil Erzurum, MD and Muzaffar Ahmad, MD
        • Cleveland Clinic Journal of Medicine September 1995, 62 (5) 293-304;
        • Anti-inflammatory drugs for maintenance therapy, use of beta agonists, emergency management, immunotherapy, and newer therapies.

      • Evaluating unexplained syncope with upright tilt testing

        Wishwa N. Kapoor, MD, MPH
        • Cleveland Clinic Journal of Medicine September 1995, 62 (5) 305-310;
        • A review of this problematic technique for diagnos ing vasovagal syncope and recommendations for its use.

      • Accuracy and predictive values in clinical decision-making

        Mark J. Eisenberg, MD, MPH
        • Cleveland Clinic Journal of Medicine September 1995, 62 (5) 311-316;
        • The accuracy and predictive value of a diagnostic test may differ substantially between research and clinical populations, owing to differences in disease prevalence. The article suggests ways researchers could end the confusion.

  • Current Drug Therapy

      • Use of old and new oral 5-aminosalicylic acid formulations in inflammatory bowel disease

        Donald G. Vidt, MD, Aaron Brzezinski, MD, George B. Rankin, MD, Douglas L. Seidner, MD and Bret A. Lashner, MD, MPH
        • Cleveland Clinic Journal of Medicine September 1995, 62 (5) 317-323;
        • Sulfasalazine, a 5-ASA agent, is the anti-inflammatory agent of choice for ulcerative colitis and Crohn's disease. Newer delayed-release formulations can also be appropriate first-line agents.

  • Cancer Diagnosis and Management

      • An update on prostate cancer

        Maurie Markman, MD and Eric A. Klein, MD
        • Cleveland Clinic Journal of Medicine September 1995, 62 (5) 325-338;
        • The diagnosis and treatment of prostate cancer, including the role of screening and treatment strategies for localized and advanced tumors.

  • Editorial